4.0 Article

Inhibition of Protein Kinase C β2 Prevents Tumor Necrosis Factor-α-Induced Apoptosis and Oxidative Stress in Endothelial Cells: The Role of NADPH Oxidase Subunits

Journal

JOURNAL OF VASCULAR RESEARCH
Volume 49, Issue 2, Pages 144-159

Publisher

KARGER
DOI: 10.1159/000332337

Keywords

Protein kinase C beta(2); Human umbilical vein endothelial cells; Reactive oxygen species; NADPH oxidase; Apoptosis

Funding

  1. National Nature Science Foundation of China [30770899]
  2. Nature Science Foundation of Guangdong province of China [815100890100072]

Ask authors/readers for more resources

We investigate the cell signal transduction pathway protein kinase C (PKC) and the role of NADPH subunits in the process of TNF-alpha-induced endothelial apoptosis. Human umbilical vein endothelial cells (HUVEC) were treated with one of these: 1 m M PKC beta(2) inhibitor CGP53353, 10 m M PKC delta inhibitor rottlerin, combination CGP53353 with rottlerin, 3 x 10(-4) M NADPH oxidase inhibitor apocynin, 5 x 10(-6) M NADPH oxidase peptide inhibitor gp91ds-tat. The apoptosis process was assessed by Hoechst 33342 stain, flow cytometry and Western blot analysis, while intracellular reactive oxygen species (ROS) production was detected by 2,7'-dichlorodihydrofluorescein diacetate (DCFH-DA). The NADPH oxidase subunit gene and protein expression were assessed by quantitative real-time PCR and Western blot analysis, respectively. TNF-alpha significantly induced HUVEC apoptosis and ROS production, accompanying with dramatic upregulation of NADPH oxidase subunits: NOX2/gp91(phox), NOX4, p47(phox) and p67(phox), whereas these enhancements were abolished by the treatment with PKC inhibitors. High TNF-alpha level exposure induces HUVEC apoptosis, as well as a ROS generation increase via the PKC beta(2) -dependent activation of NADPH oxidase. Although the PKC delta pathway may enhance TNF-alpha induced HUVEC apoptosis, it does not involve the ROS pathway. Upregulation of expression of NADPH subunits is important in this process, which leads to a new target in antioxidative therapy for vascular disease prevention. Copyright (C) 2012 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available